Skip to main content
. 2020 May 8;20:402. doi: 10.1186/s12885-020-06906-1

Table 2.

Tumor and treatment related parameters

Per patients (1st lesion) Per lesion (treatment)
Prescription
 3 × 6.67Gy (BED10: 33.36 Gy) 0 (0%) 2 (1.5%)
 5x7Gy (BED10: 59.5 Gy) 1 (1%) 3 (2.3%)
 5x8Gy (BED10: 72 Gy) 5 (4.8%) 5 (3.8%)
 5x9Gy (BED10: 85.5 Gy) 5 (4.8%) 7 (5.3%)
 5x10Gy (BED10: 100 Gy) 13 (12.5%) 15 (11.4%)
 5x11Gy (BED10: 115.5 Gy) 9 (8.7%) 11 (8.3%)
 5x12Gy (BED10: 132 Gy) 10 (9.6%) 11 (8.3%)
 3x15Gy (BED10: 112.5 Gy) 2 (1.9%) 4 (3.0%)
 3x17Gy (BED10: 137.7 Gy) 3 (2.9%) 1 (0.8%)
 3x20Gy (BED10: 180 Gy) 56 (53.8%) 73 (55.3%)
Tracking
 Synchrony 44 (42.3%) 56 (42.4%)
 Xsight Lung 13 (12.5%) 16 (12.1%)
 Xsight Spine 47 (45.2%) 60 (45.5%)
RECIST
 Complete Remission 63 (60.6%) 76 (57.6%)
 Partian Remission 12 (11.5%) 15 (11.4%)
 Stable Disease 4 (3.8%) 5 (3.8%)
 Progressive Disease 25 (24%) 36 (27.3%)
Treatment execution
Per lesion/treatment
Nr. of beams
 Average (Range) 120 (35–230)
Total MU
 Average (Range) 37,821 (11902–89,666)
Volumes (Mean, (Range) in cm3)
 GTV 7.9 (0.3–105.2)
 CTV 19.0 (1.4–147)
 PTV 25.3 (2.8–178.7)
Dosimetric parameters (Mean, (95% CI) in Gy)
 GTV-D98 58.3 (30.0–70.2)
 GTV-D90 60.7 (33.3–71.6)
 GTV-Dmean 64.7 (43.2–73.2)
 GTV-D2 68.9 (48.5–75.2)
 GTV-BED10Gy D98 162.6 (49.1–234.6)
 GTV-BED10Gy D95 167.4 (52.8–238.3)
 GTV-BED10Gy D90 172.4 (55.7–242.6)
 GTV-BED mean 189.8 (80.8–251.8)
 GTV-BED10Gy D2 208.8 (95.5–264.0)
 CTV-D98 55.6 (27.5–66.4)
 CTV-D90 59.0 (35.0–68.4)
 CTV-Dmean 63.6 (43.3–71.4)
 CTV-BED10Gy D98 150.8 (44.0–213.6)
 CTV-BED10Gy D95 157.5 (51.3–218.4)
 CTV-BED10Gy D90 163.9 (61.3–224.2)
 CTV-BED mean 184.4 (81.0–241.4)
 PTV-D98 52.5 (23.7–61.8)
 PTV-D90 56.3 (32.1–64.5)
 PTV-Dmean 62.0 (42.6–69.5)
 PTV-BED10Gy D98 137.6 (37.0–189.2)
 PTV-BED10Gy D95 144.7 (42.4–197.4)
 PTV-BED10Gy D90 151.7 (55.0–203.4)
 PTV-BED mean 176.5 (79.0–231)